Insufficient scRNA-seq data for expression of BATF2 at single-cell level.
Insufficient scRNA-seq data for expression of BATF2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 100% | 586.95 | 966 / 966 | 97% | 38.37 | 510 / 527 |
stomach | 100% | 360.97 | 358 / 359 | 96% | 32.53 | 275 / 286 |
pancreas | 100% | 520.66 | 328 / 328 | 90% | 13.81 | 160 / 178 |
kidney | 100% | 510.24 | 89 / 89 | 87% | 11.43 | 780 / 901 |
lung | 99% | 518.23 | 575 / 578 | 85% | 16.01 | 976 / 1155 |
bladder | 100% | 267.71 | 21 / 21 | 67% | 18.73 | 338 / 504 |
ovary | 90% | 147.98 | 162 / 180 | 74% | 9.84 | 319 / 430 |
uterus | 90% | 112.02 | 153 / 170 | 72% | 14.91 | 331 / 459 |
esophagus | 82% | 199.30 | 1184 / 1445 | 71% | 15.95 | 130 / 183 |
brain | 85% | 132.34 | 2256 / 2642 | 66% | 8.03 | 467 / 705 |
liver | 99% | 253.14 | 223 / 226 | 53% | 5.62 | 215 / 406 |
breast | 94% | 142.69 | 432 / 459 | 56% | 9.25 | 629 / 1118 |
thymus | 98% | 210.07 | 637 / 653 | 49% | 4.89 | 297 / 605 |
adrenal gland | 99% | 427.44 | 256 / 258 | 35% | 2.77 | 80 / 230 |
skin | 34% | 36.21 | 616 / 1809 | 89% | 23.71 | 421 / 472 |
prostate | 100% | 283.17 | 244 / 245 | 22% | 1.52 | 111 / 502 |
spleen | 100% | 1415.43 | 241 / 241 | 0% | 0 | 0 / 0 |
muscle | 98% | 210.03 | 784 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 94% | 19.44 | 75 / 80 |
adipose | 90% | 153.18 | 1088 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 86% | 13.58 | 25 / 29 |
blood vessel | 84% | 125.06 | 1118 / 1335 | 0% | 0 | 0 / 0 |
heart | 84% | 107.06 | 720 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 78% | 14.70 | 35 / 45 |
peripheral blood | 68% | 224.12 | 635 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0140467 | Biological process | integrated stress response signaling |
GO_0042832 | Biological process | defense response to protozoan |
GO_0043011 | Biological process | myeloid dendritic cell differentiation |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0090575 | Cellular component | RNA polymerase II transcription regulator complex |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
Gene name | BATF2 |
Protein name | Basic leucine zipper transcriptional factor ATF-like 2 (B-ATF-2) (Suppressor of AP-1 regulated by IFN) (SARI) Basic leucine zipper ATF-like transcription factor 2 Basic leucine zipper ATF-like transcription factor 2 (cDNA FLJ54822) |
Synonyms | |
Description | FUNCTION: AP-1 family transcription factor that controls the differentiation of lineage-specific cells in the immune system. Following infection, participates in the differentiation of CD8(+) thymic conventional dendritic cells in the immune system. Acts via the formation of a heterodimer with JUN family proteins that recognizes and binds DNA sequence 5'-TGA[CG]TCA-3' and regulates expression of target genes (By similarity). Selectively suppresses CCN1 transcription and hence blocks the downstream cell proliferation signals produced by CCN1 and inhibits CCN1-induced anchorage-independent growth and invasion in several cancer types, such as breast cancer, malignant glioma and metastatic melanoma. Possibly acts by interfering with AP-1 binding to CCN1 promoter. . |
Accessions | B4DV37 ENST00000435842.2 [Q8N1L9-2] ENST00000301887.9 [Q8N1L9-1] Q8N1L9 ENST00000527716.1 ENST00000534177.1 E9PJ73 |